GDRX, Looks OK, this n September 22, 2022, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) approved (i) an annual base salary increase from $428,000 to $450,000 and a target bonus opportunity increase from 30% to 100% of annual base salary, each effective as of July 1, 2022, for Karsten Voermann, the Company’s Chief Financial Officer; and (ii) an annual base salary increase from $333,000 to $400,000, effective as of July 1, 2022, for Babak Azad, the Company’s Chief Marketing Officer and SVP, Marketing & Communications So what, from an 8K. Perhaps undervalued or smoke and mirrors accounting.